Evaluation of treatment adherence in type 1 diabetes: a novel approach.
about
Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial.Does increased adherence to medications change health care financial burdens for adults with diabetes?
P2860
Evaluation of treatment adherence in type 1 diabetes: a novel approach.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Evaluation of treatment adherence in type 1 diabetes: a novel approach.
@en
Evaluation of treatment adherence in type 1 diabetes: a novel approach.
@nl
type
label
Evaluation of treatment adherence in type 1 diabetes: a novel approach.
@en
Evaluation of treatment adherence in type 1 diabetes: a novel approach.
@nl
prefLabel
Evaluation of treatment adherence in type 1 diabetes: a novel approach.
@en
Evaluation of treatment adherence in type 1 diabetes: a novel approach.
@nl
P2093
P2860
P1476
Evaluation of treatment adherence in type 1 diabetes: a novel approach
@en
P2093
P2860
P304
P356
10.1111/J.1365-2362.2007.01771.X
P577
2007-03-01T00:00:00Z